SCHEMBL4136313

SCHEMBL4136313

CCCc1nn(C(C)C)c2c(=O)[nH]c(N(Cc3ccc(F)cc3)CC3CCCCC3)nc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 7/20 0.36
PDE3A Q14432 2/20 0.36
PDE3B Q13370 1/20 0.36
MDM2 Q00987 1/20 0.33
KMT2A Q03164 4/20 0.33
ALDH1A1 P00352 3/20 0.33
LMNA P02545 2/20 0.33
GRIN2A Q12879 2/20 0.32
MEN1 O00255 3/20 0.32
HPGD P15428 1/20 0.32
PDE1A P54750 1/20 0.32
PDE1B Q01064 1/20 0.32
PDE1C Q14123 1/20 0.32
TP53 P04637 1/20 0.31
PDE9A O76083 1/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
GRIA2 P42262 1/20 0.31
TSHR P16473 2/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8032549 0.83 PDE5A (0.36) PDE5APDE3APDE3BKMT2APDE1A
SCHEMBL4130410 0.80 PARP1 (0.34) KMT2AALDH1A1LMNAGRIN2AMEN1
SCHEMBL4132769 0.77 PDE5A (0.42) PDE5APDE3APDE3BKMT2AALDH1A1
SCHEMBL4125201 0.77 PDE5A (0.36) PDE5APDE3APDE3BKMT2AALDH1A1
SCHEMBL4126072 0.76 PDE5A (0.42) PDE5APDE3APDE3BKMT2AALDH1A1
SCHEMBL4117755 0.76 KDM4E (0.41) PDE5APDE3APDE3BMDM2KMT2A
SCHEMBL4898303 0.76 PDE5A (0.48) PDE5APDE3APDE3BKMT2AALDH1A1
SCHEMBL8049072 0.76 PDE5A (0.48) PDE5APDE3APDE3BKMT2AALDH1A1
SCHEMBL4136868 0.73 PDE5A (0.44) PDE5APDE3APDE3BKMT2AALDH1A1
SCHEMBL8037857 0.73 PDE5A (0.42) PDE5APDE3APDE3BKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009071706-A1 PYRAZOLEPYRIMIDINE COMPOUNDS USEFUL FOR THE TREATMENT OF DEGENERATIVE & INFLAMMATORY DISEASES GALAPAGOS NV (BE) 2009-06-11 WO disclosed